What Is The Current and Historic Market Size Analysis Of The Hormone Therapy Market?
The hormone therapy market has seen considerable growth due to a variety of factors.
• The market size of hormone therapy has seen a robust increase in the past years. It is projected to expand from $19.7 billion in 2024 to $21.1 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period is a product of factors such as advancements in the medical field, revolution in women's health, enhanced awareness and education, clinical research and development, and changes in healthcare practices.
What Is The Forecast For The Hormone Therapy Market Size?
The Hormone Therapy market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the hormone therapy market is anticipated to witness significant growth, projected to escalate to $28.46 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.8%.
This anticipated expansion during the forecast period could be a result of factors such as the personalized medicine approach, changes in the demographic of the aging population, evolving attitudes towards women's health, an emphasis on wellness and longevity, along with regulatory modifications. The forecast period is also expected to see strong trends including regulatory alterations and guidelines, lifestyle modifications and associated stress, advances in research and development, and increased awareness and education.
What Are The Essential Drivers Behind The Growth Of The Hormone Therapy Market?
The hormone therapy market is experiencing significant growth due to a rise in hormone imbalance disorders. Hormone imbalance is a condition in which the body either overproduces or underproduces a certain hormone, resulting in disorders such as hypothyroidism, hypogonadism, and growth hormone deficiency among others. Treatments for these disorders often involve hormone therapies like estrogen replacement, testosterone replacement, and insulin therapy. This trend is highlighted in a 2022 report from London Medical Laboratory, a diagnostics and phlebotomy provider in the UK, which predicted a 19% increase in significant hormone imbalances compared to two years earlier. This anticipated rise in hormone imbalance disorders will inevitably boost the hormone therapy market.
How Is The Global Hormone Therapy Market Divided Into Key Segments?
The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy
2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones
3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid
4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets
Pre-Book The Hormone Therapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Hormone Therapy Market?
Key players in the hormone therapy market are working on creating innovative solutions like direct-to-consumer telehealth models for hormone therapy to improve patient accessibility and convenience. This kind of telehealth model refers to a healthcare delivery method that allows patients to acquire hormone therapy services remotely, circumventing the need for the traditional face-to-face consultations. For example, in September 2023, LifeMD, an American telehealth company, collaborated with ASCEND Therapeutics, a pharmaceutical company also based in the US, to introduce a comprehensive direct-to-consumer telehealth model for hormone therapy with a focus on using EstroGel (estradiol gel) to ease the symptoms of menopause. This collaboration resulted in patients having the ability to directly access LifeMD's telehealth services from the EstroGel website, making consultations with certified healthcare professionals who can prescribe the medication and organise home delivery, more accessible. This initiative, by simplifying access and tackling issues such as extended wait times, aims to improve health outcomes for women in need of menopause treatment.
Who Are the Key Players In The Hormone Therapy Market?
Major companies operating in the hormone therapy market include:
• Abbott Laboratories
• Bayer AG
• Eli Lilly and Company
• F. Hoffmann-La Roche
• Merck KGaA
• Mylan NV
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Abbvie Inc.
• Teva Pharmaceutical Industries Ltd.
• Perrigo Company Plc.
• Cipla Inc.
• Lupin Limited
• Sun Pharmaceuticals Industries Ltd.
• Hikma Pharmaceuticals PLC.
• Johnsons & Johnsons Services Inc.
• Boehringer Ingelheim International GmbH
• Sanofi S.A.
• AstraZeneca plc
• TherapeuticsMD Inc.
• Amgen Inc.
• Genentech Inc.
• Dr. Reddy's Laboratories Ltd
• Allergan PLC
• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• Takeda Pharmaceutical Company Limited
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
What Are The Regional Insights Into The Hormone Therapy Market?
North America was the largest region in the hormone therapy market in 2024. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
